NL-OMON56348
Not yet recruiting
Not Applicable
Genetic screening in Parkinson*s disease patients to identify GBA1 mutation carriers for future clinical trials. - Genetic screening for GBA1
Vanqua Bio Inc.0 sites1,000 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Parkinson's disease
- Sponsor
- Vanqua Bio Inc.
- Enrollment
- 1000
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Age 40\-80 years of age at screening (inclusive).
- •2\. All participants must understand and provide written informed consent prior
- •to any study\-specific procedures
- •3\. Able to speak, read, and understand study procedures in Dutch sufficiently
- •to allow completion of all study assessments.
- •4\. Patient\-reported clinical diagnosis of Parkinson\*s disease by a neurologist
- •within the last 10 years.
Exclusion Criteria
- •1\. Known non\-GBA\-1 mutation for Parkinson\*s disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Genetic screening for GBA1 in Parkinson’s disease patientsParkinson's disease, ParkinsonismNervous System DiseasesISRCTN99451262Vanqua Bio Inc.1,000
Completed
Not Applicable
Genetic screening in Parkinson*s Disease in order to identify patients who can participate in clinical trials with new targeted therapiesmovement disorderParkinson's disease10028037NL-OMON45734Centre for Human Drug Research1,000
Recruiting
Not Applicable
Study to investigate mutations in the GBA1 and LRRK2 genes in Parkinson’s Disease patients.Parkinson’s DiseaseNL-OMON23101CHDR1,000
Not yet recruiting
Not Applicable
Search for Genetic Factors in Parkinson's Disease - IINL-OMON51549Erasmus MC, Universitair Medisch Centrum Rotterdam700
Completed
Not Applicable
Search for Genetic Factors in Parkinson*s diseaseParkinsonismParkinson's Disease1002929910028037NL-OMON37785Erasmus MC, Universitair Medisch Centrum Rotterdam700